Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in INCY — Incyte Corp

CIK 1603466 STAMFORD, CT
Back to INCY Full portfolio

Position in INCY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,883,973
-$24,576,588 QoQ
Shares Held
168,763
-64.6% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Derivatives in INCY

reported options exposure · as of Mar 31, 2026
CallValue
$414,128
CallShares
4,400
PutValue
$291,772
PutShares
3,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in INCY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,883,973 168,763
2026-03-31 $291,772 3,100
2026-03-31 $414,128 4,400
2025-09-30 $669,999 7,900
2025-09-30 $669,999 7,900
2025-09-30 $40,460,561 477,073
2025-06-30 $67,084,152 985,083
2025-03-31 $20,708,947 342,014
2024-12-31 $23,103,915 334,500
2024-12-31 $88,296,946 1,278,369
2024-09-30 $156,610,730 2,369,300
2024-03-31 $21,654,297 380,100
2021-12-31 $17,542,600 239,000
2020-12-31 $42,420,146 487,700
2020-09-30 $23,423,127 261,011
2020-03-31 $34,063,740 465,161